The MFDS plays a key role in approving generic drugs by evaluating their bioequivalence to reference products, ensuring the same safety, efficacy, and quality standards. It reviews detailed data on formulation, manufacturing processes, and clinical studies before granting approval, enabling safe and... Read More
The MFDS monitors drug safety post-approval through pharmacovigilance programs, adverse event reporting, and periodic safety updates from manufacturers. It conducts inspections, risk assessments, and may request additional studies if necessary. The MFDS can issue warnings, modify drug labeling, or withdraw approvals to... Read More
The MFDS process for approving biologics in South Korea involves submitting a comprehensive application that includes preclinical and clinical trial data. The MFDS reviews safety, efficacy, and manufacturing quality. It also conducts facility inspections to ensure compliance with Good Manufacturing Practices (GMP)... Read More
The MFDS reviews New Drug Applications for safety and efficacy by examining clinical trial data, including study design, methodologies, and results. The agency assesses risk-benefit profiles, evaluates adverse event data, and may consult expert panels. This thorough evaluation ensures that only drugs... Read More
The purpose of pre-consultation meetings with the MFDS is to provide pharmaceutical companies an opportunity to discuss their drug development plans and regulatory requirements. These meetings help clarify submission processes, address potential concerns, and ensure that applicants understand expectations, facilitating smoother applications... Read More
The MFDS handles post-marketing surveillance in South Korea by monitoring the safety and efficacy of approved drugs through adverse event reporting systems. It collects data from healthcare providers and patients, analyzes trends, and conducts periodic reviews. The MFDS can issue safety warnings,... Read More
The key responsibilities of the MFDS in drug approval include evaluating safety and efficacy data, reviewing clinical trial results, and ensuring compliance with regulatory standards. The agency conducts facility inspections, oversees post-marketing surveillance, and monitors adverse events. Additionally, the MFDS provides guidance... Read More
The MFDS conducts facility inspections for Good Manufacturing Practice (GMP) compliance by evaluating manufacturing processes, quality control systems, and documentation practices. Inspectors assess facility conditions, equipment, and personnel qualifications. They review records, conduct interviews, and ensure adherence to regulatory standards, providing reports... Read More
The requirements for quality data in drug registration with the MFDS include comprehensive documentation of manufacturing processes, control measures, and product specifications. Data must demonstrate consistent quality, stability, and purity of the drug. Additionally, compliance with Good Manufacturing Practices (GMP) and detailed... Read More
Preclinical data plays a crucial role in the MFDS drug registration process by providing initial evidence of a drug’s safety and biological activity. This data, obtained from laboratory and animal studies, helps the MFDS evaluate potential risks, informs clinical trial design, and... Read More